Friday, 6 November 2026
M
Meridian Globe
Live briefing
Japan's trading house chiefs warn of uncertainty after US midterms— 日经 Nikkei AsiaJapan contractor's AI-guided tunnel boring outperforms human operators— 日经 Nikkei AsiaUS midterms live: Nasdaq tumbles 4% on AI regulation fears— 日经 Nikkei AsiaSony raises annual profit forecast on Spider-Man hit, gaming gains— 日经 Nikkei AsiaIndonesia's GDP grows 5.5% in Q3, helped by government spending— 日经 Nikkei AsiaToyota ready to 'regain market share' in China on expanded local sourcing— 日经 Nikkei AsiaTaiwan's chipmakers shine brightest in living memory— 日经 Nikkei AsiaAsian stock markets drop as Democratic win stokes fears over AI scrutiny— 日经 Nikkei AsiaJapan's trading house chiefs warn of uncertainty after US midterms— 日经 Nikkei AsiaJapan contractor's AI-guided tunnel boring outperforms human operators— 日经 Nikkei AsiaUS midterms live: Nasdaq tumbles 4% on AI regulation fears— 日经 Nikkei AsiaSony raises annual profit forecast on Spider-Man hit, gaming gains— 日经 Nikkei AsiaIndonesia's GDP grows 5.5% in Q3, helped by government spending— 日经 Nikkei AsiaToyota ready to 'regain market share' in China on expanded local sourcing— 日经 Nikkei AsiaTaiwan's chipmakers shine brightest in living memory— 日经 Nikkei AsiaAsian stock markets drop as Democratic win stokes fears over AI scrutiny— 日经 Nikkei Asia

Correction: T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: a study from the ALWP/EBMT

Source Nature 医学研究17h ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
Global
Language
English
Item ID
health-978d43ec

Comments 0 comments

No comments yet. Be the first.

Correction: T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: a study from the ALWP/EBMT · Meridian Globe